Business1 min read

Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge

By · Via Investing.com Markets · Published by Everything Blog

In short

Bristol Myers announced an upward revision to its expected net revenue for fiscal year 2026. However, overall profitability expectations have simultaneously been reduced for the same period. The pharmaceutical company cited a specific incurred charge as the direct reason for lowering its projected earnings per share.

Key points

  • Higher expected sales over the next few years provide strong top-line momentum for the co…: Higher expected sales over the next few years provide strong top-line momentum for the company.
  • Unanticipated charges continue to compress projected bottom-line profitability and per-sh…: Unanticipated charges continue to compress projected bottom-line profitability and per-share earnings results.
  • Future financial targets reflect a divergence between accelerating revenue and constraine…: Future financial targets reflect a divergence between accelerating revenue and constrained earnings power.
Business